Researchers suggest a vaccine could replace multiple jabs every year for seasonal respiratory infections and be on hand in the event of a new pandemic.

An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory ...

“One of the strengths of the study is that it explains in detail how this works. The researchers show that vaccine-activated T cells — a type of white blood cell — can “reprogramme” other immune cells ...

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a ...

The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...

A postdoctoral scholar position is open to study mucosal immunology relevant to bronchopulmonary dysplasia (BPD) and chronic obstructive pulmonary disease (COPD). The position is funded by the ...